Clinical Trial Update: Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation [NA]

View source ↗

Summary

Completed clinical trial evaluating pre-emptive treatments in lupus nephritis patients with serological reactivation. Conducted by The University of Hong Kong.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Snippet

Sponsor: The University of Hong Kong | Conditions: Lupus Nephritis | NA | Status: COMPLETED